ArticleCellular and molecular life sciences : CMLS2026
DJ-1 promotes necroptosis of chondrocytes by the PTEN/PI3K-AKT signaling pathway.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Osteoarthritis (OA) is a common degenerative joint disease characterized by progressive cartilage degradation. Necroptosis has been recognized as a process closely associated with OA progression; however, its precise underlying mechanisms remain elusive. In this study, we found that the expression levels of DJ-1 and p-MLKL were significantly elevated in human OA cartilage tissue. Transmission electron microscopy revealed typical necroptotic morphology in OA chondrocytes. In vitro experiments demonstrated that DJ-1 overexpression exacerbated TSZ + LPS-induced chondrocyte necroptosis and disrupted extracellular matrix (ECM) metabolism. The PI3K/AKT signaling pathway can be involved in TNF-mediated necroptosis, while PTEN, as a negative regulator, inhibits the activation of this pathway primarily by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Co-immunoprecipitation (Co-IP) assays showed that DJ-1 directly binds to and inhibits PTEN, thereby relieving its suppression of the PI3K/AKT signaling pathway. Treatment with the PI3K inhibitor LY294002 significantly alleviated DJ-1-induced chondrocyte necroptosis and ECM dysregulation. Furthermore, in vivo studies confirmed that DJ-1 knockdown attenuated DMM-induced OA progression and improved cartilage and subchondral bone structure. Collectively, these findings indicate that DJ-1 promotes chondrocyte necroptosis and ECM degradation through regulation of the PTEN/PI3K/AKT signaling pathway, thereby accelerating the onset and progression of OA. This may provide a new therapeutic target for the treatment of OA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.